Ryan C Holcomb

Title: The Innovative Contributions of Ryan C Holcomb

Introduction

Ryan C Holcomb is a notable inventor based in Bellevue, WA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of bradykinin antagonists. With a total of 2 patents to his name, Holcomb's work is paving the way for advancements in medical treatments.

Latest Patents

Holcomb's latest patents include "Sulfonylbenzodiazepinone acetamides as bradykinin antagonists." This patent discloses compounds that serve as bradykinin antagonists, which are useful in treating diseases or alleviating symptoms associated with conditions mediated by bradykinin. Certain compounds in this patent exhibit increased potency and are expected to have an extended duration of action. Another significant patent is "Sulfonylquinoxalone derivatives as bradykinin antagonists." This patent reveals 1-sulfonylquinoxalone acetamides and their derivatives, which are also effective as bradykinin antagonists.

Career Highlights

Ryan C Holcomb is currently employed at Elan Pharmaceuticals, Inc., where he continues to innovate and contribute to the pharmaceutical industry. His work focuses on developing new compounds that can lead to better therapeutic options for patients.

Collaborations

Holcomb collaborates with talented individuals in his field, including Francine S Grant and Michael A Pleiss. These collaborations enhance the research and development process, leading to more effective solutions in the pharmaceutical sector.

Conclusion

Ryan C Holcomb's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his commitment to advancing medical science. His work is instrumental in developing new treatments that can significantly improve patient outcomes.